Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study
Authors:
- E.M. van der WillikEWE.M. van der Willik
- M.I. van Berge HenegouwenM.I. van Berge Henegouwen
- B.P.L. WijnhovenB.P.L. Wijnhoven
- K. BosschaKBK. Bosscha
- N.C.T. van GriekenNGN.C.T. van Grieken
- H.H. HartgrinkHHH.H. Hartgrink
- R. van HillegersbergRHR. van Hillegersberg
- V.E.P.P. LemmensVLV.E.P.P. Lemmens
- J.T. PlukkerJPJ.T. Plukker
- 1 March 2018
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 91, 76-85
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Association of Intervals Between Neoadjuvant Chemoradiation and Surgical Resection With Pathologic Complete Response and Survival in Patients With Esophageal CancerJAMA Surgery, 2016
- Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studiesDiseases of the Esophagus, 2015
- Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trialThe Lancet Oncology, 2015
- Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ PreservationJournal of the American College of Surgeons, 2015
- Increased Time From Neoadjuvant Chemoradiation to Surgery Is Associated With Higher Pathologic Complete Response Rates in Esophageal CancerThe Annals of Thoracic Surgery, 2015
- Neoadjuvant Chemoradiation and Duration of Chemotherapy Before Surgical Resection for Pancreatic Cancer: Does Time Interval Between Radiotherapy and Surgery Matter?Annals of Surgical Oncology, 2013
- An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal CancerAnnals of Surgical Oncology, 2008
- Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldJournal of Clinical Oncology, 2006
- Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved SurvivalJournal of Clinical Oncology, 2005
- Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiationCancer, 2005